Cargando…
The use of CA-50 radioimmunoassay in differentiating benign and malignant pancreatic disease.
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
1986
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001389/ https://www.ncbi.nlm.nih.gov/pubmed/3459510 |
| _version_ | 1782135594650959872 |
|---|---|
| author | Habib, N. A. Hershman, M. J. Haberland, F. Papp, L. Wood, C. B. Williamson, R. C. |
| author_facet | Habib, N. A. Hershman, M. J. Haberland, F. Papp, L. Wood, C. B. Williamson, R. C. |
| author_sort | Habib, N. A. |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2001389 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 1986 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-20013892009-09-10 The use of CA-50 radioimmunoassay in differentiating benign and malignant pancreatic disease. Habib, N. A. Hershman, M. J. Haberland, F. Papp, L. Wood, C. B. Williamson, R. C. Br J Cancer Research Article Nature Publishing Group 1986-05 /pmc/articles/PMC2001389/ /pubmed/3459510 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Research Article Habib, N. A. Hershman, M. J. Haberland, F. Papp, L. Wood, C. B. Williamson, R. C. The use of CA-50 radioimmunoassay in differentiating benign and malignant pancreatic disease. |
| title | The use of CA-50 radioimmunoassay in differentiating benign and malignant pancreatic disease. |
| title_full | The use of CA-50 radioimmunoassay in differentiating benign and malignant pancreatic disease. |
| title_fullStr | The use of CA-50 radioimmunoassay in differentiating benign and malignant pancreatic disease. |
| title_full_unstemmed | The use of CA-50 radioimmunoassay in differentiating benign and malignant pancreatic disease. |
| title_short | The use of CA-50 radioimmunoassay in differentiating benign and malignant pancreatic disease. |
| title_sort | use of ca-50 radioimmunoassay in differentiating benign and malignant pancreatic disease. |
| topic | Research Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001389/ https://www.ncbi.nlm.nih.gov/pubmed/3459510 |
| work_keys_str_mv | AT habibna theuseofca50radioimmunoassayindifferentiatingbenignandmalignantpancreaticdisease AT hershmanmj theuseofca50radioimmunoassayindifferentiatingbenignandmalignantpancreaticdisease AT haberlandf theuseofca50radioimmunoassayindifferentiatingbenignandmalignantpancreaticdisease AT pappl theuseofca50radioimmunoassayindifferentiatingbenignandmalignantpancreaticdisease AT woodcb theuseofca50radioimmunoassayindifferentiatingbenignandmalignantpancreaticdisease AT williamsonrc theuseofca50radioimmunoassayindifferentiatingbenignandmalignantpancreaticdisease AT habibna useofca50radioimmunoassayindifferentiatingbenignandmalignantpancreaticdisease AT hershmanmj useofca50radioimmunoassayindifferentiatingbenignandmalignantpancreaticdisease AT haberlandf useofca50radioimmunoassayindifferentiatingbenignandmalignantpancreaticdisease AT pappl useofca50radioimmunoassayindifferentiatingbenignandmalignantpancreaticdisease AT woodcb useofca50radioimmunoassayindifferentiatingbenignandmalignantpancreaticdisease AT williamsonrc useofca50radioimmunoassayindifferentiatingbenignandmalignantpancreaticdisease |